Here's something the supplement industry doesn't want you to know: that $30 multivitamin you've been taking for 15 years is probably doing almost nothing. Most generic multivitamins use the cheapest forms of each nutrient -- magnesium oxide instead of glycinate, cyanocobalamin instead of methylcobalamin -- at doses too low to move the needle on any biomarker.
The market figured this out. Between 2020 and 2025, multivitamin sales flatlined while targeted longevity compounds exploded. NMN sales alone grew 400% in three years. Consumers stopped asking "am I getting my vitamins?" and started asking "what's my NAD+ level doing?"
That's a fundamentally different question. And it demands fundamentally different products.
The biggest shift in supplements isn't a new molecule. It's information. Companies like InsideTracker, Function Health, and Viome now build supplement protocols from your actual biomarkers -- not from a quiz on a website.
When you can see that your omega-3 index is 4.2% (it should be above 8%), your vitamin D is 22 ng/mL (it should be 50+), and your hsCRP is elevated, you don't grab a random bottle off the shelf. You build a targeted protocol and you retest in 90 days to see if it worked.
This feedback loop changes everything. Supplements stop being an act of faith and become a measurable intervention. And the companies selling fairy dust in capsules? They can't survive in a world where customers demand proof.
The compounds getting the most serious attention right now didn't exist in consumer form ten years ago. NMN and NR for NAD+ restoration. Fisetin and quercetin as senolytic agents. Spermidine for autophagy. Urolithin A for mitochondrial function. These aren't fringe -- they're backed by peer-reviewed research and being taken by the scientists who study aging.
The average serious longevity stack in 2026 runs $150 to $400 a month. That sounds expensive until you compare it to the cost of chronic disease treatment, which averages $12,000 a year in the US for people over 65.
Prevention is always cheaper than treatment. Always.
Within five years, you'll spit into a tube, upload your bloodwork, and an AI will generate a supplement protocol tailored to your genetics, your current biomarkers, and your health goals. It'll adjust quarterly based on new data. The pills might even be compounded on demand -- your exact doses, your exact forms, in one daily pack.
The supplement industry spent decades selling hope in a bottle. The future is selling outcomes in a bottle -- measured, tracked, and optimized. If your supplement company can't show you what their product actually did to your biomarkers, they won't exist in 2030.
The pill didn't change. Your expectations did. And that changes everything.
Science-backed health tips delivered every week.